Laureate Pharma Elects New Chairman; Tracy Ken Tsuetaki Augments Organization, Providing Guidance and Strategic Direction

		Laureate Pharma is a full-service biopharmaceutical development and protein production company located in Princeton, New Jersey. Laureate Pharma offers superior bioprocessing services that accelerate new products from development through production. Laureate provides a wide range of specialized services from process design and development to full-scale cGMP production, purification, aseptic filling, testing, validation, analytical services, and regulatory support. Laureate is focused on two active segments of the biopharmaceutical industry: monoclonal antibodies and recombinant protein products. (PRNewsFoto/LAUREATE PHARMA, INC.) PRINCETON, NJ UNITED STATES

PRINCETON, N.J., Feb. 28 /PRNewswire/ -- Laureate Pharma, Inc. a full- service biopharmaceutical development and protein production company, announced today the election of Tracy Ken Tsuetaki as Laureate's new non- executive Chairman of its Board of Directors. (Logo: http://www.newscom.com/cgi-bin/prnh/20020723/LPHARMLOGO ) Chartered with providing expert guidance and strategic direction, Dr. Tsuetaki brings to Laureate more than 20 years of experience in the healthcare, pharmaceutical, biotechnological and medical products industries. Throughout his career, he has worked in general management, sales and marketing, strategy, business development, and pharmaceutical product development. "Tracy's unique blend of project management expertise, in-depth knowledge of customer needs, and strong leadership skills will enable us to drive Laureate's growth and development and to achieve worldwide recognition for our fully-integrated contract development and bioprocessing services," said Robert J. Broeze, President & Chief Executive Officer of Laureate. "As we continue to enhance the value proposition for our customers and to build upon the momentum that we achieved in 2006, we look to our new partnership with Tracy to help facilitate our objectives for 2007 and beyond." Currently, Dr. Tsuetaki is President of Medical Communications and Consulting at Quintiles Transnational where he is responsible for their global consulting and medical education groups. Previously, he was Senior Vice President of Global Business Development for Quintiles and was responsible for Global Sales and Marketing. Dr. Tsuetaki's broad industry experience also includes positions as Senior Vice President for Strategic Planning and Consulting for Kaiser Permanente and as an Account Executive with Ernst & Young's Management Consulting group where he focused his life science consulting practice on strategy and performance improvement in marketing, sales, R&D and manufacturing. About Laureate Pharma, Inc. Laureate Pharma is a full-service biopharmaceutical development and protein production company located in Princeton, New Jersey. Laureate offers superior bioprocessing services that accelerate new products from development through production. Laureate provides a wide range of specialized services from process design and development to full-scale cGMP production, purification, aseptic filling, testing, validation, analytical services, and regulatory support. Laureate is focused on two active segments of the biopharmaceutical industry: monoclonal antibodies and recombinant protein products. Laureate is a partner company of Safeguard Scientifics, Inc. (NYSE: SFE), which builds value in high-growth, revenue stage technology and life sciences businesses (http://www.safeguard.com.) For more information, contact Michael Cavanaugh, Vice President Sales, Marketing, and Business Development at (609) 919-3400, or info@laureatepharma.com or visit http://www.laureatepharma.com.